[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hammen et al., 2003 - Google Patents

Clinical applications of 1H‐MR spectroscopy in the evaluation of epilepsies–What do pathological spectra stand for with regard to current results and what answers do …

Hammen et al., 2003

Document ID
386330663012419567
Author
Hammen T
Stefan H
Eberhardt K
W‐Huk B
Tomandl B
Publication year
Publication venue
Acta neurologica scandinavica

External Links

Snippet

Nuclear magnetic resonance spectroscopy (1H‐MRS) is a non‐invasive method in detecting abnormal spectra of various brain metabolites containing N‐acetylaspartate (NAA), Choline (Cho), Creatine (Cr), γ‐Aminobutyric acid (GABA) and Glutamate. Technical processing of …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves

Similar Documents

Publication Publication Date Title
Soares et al. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
Hammen et al. Clinical applications of 1H‐MR spectroscopy in the evaluation of epilepsies–What do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies?
Neal et al. Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging
Kantarci et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease
Siddall et al. Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report
Salmenpera et al. Imaging in epilepsy
Astley et al. Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders
Casse et al. Positron emission tomography and epilepsy
Wang et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T
Salmenpera et al. Evaluation of quantitative magnetic resonance imaging contrasts in MRI‐negative refractory focal epilepsy
Grachev et al. Aging alters regional multichemical profile of the human brain: an in vivo1H‐MRS study of young versus middle‐aged subjects
Walecki et al. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI)
Wang et al. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR‐based techniques as objective upper motor neuron markers
US9612306B2 (en) Method for assessing repetitive head injuries with two-dimensional magnetic resonance spectroscopy
Marjańska et al. Distinctive neurochemistry in Alzheimer’s disease via 7 T in vivo magnetic resonance spectroscopy
Gonen et al. Seven‐tesla quantitative magnetic resonance spectroscopy of glutamate, γ‐aminobutyric acid, and glutathione in the posterior cingulate cortex/precuneus in patients with epilepsy
Aydin et al. Value of proton-MR-spectroscopy in the diagnosis of temporal lobe epilepsy; correlation of metabolite alterations with electroencephalography
Zhang et al. Identifying the affected hemisphere with a multimodal approach in MRI-positive or negative, unilateral or bilateral temporal lobe epilepsy
Hammen et al. 1H‐MR spectroscopy indicates severity markers in temporal lobe epilepsy: correlations between metabolic alterations, seizures, and epileptic discharges in EEG
Schuff et al. Reanalysis of multislice 1H MRSI in amyotrophic lateral sclerosis
Hancu et al. 1H MR spectroscopy using TE averaged PRESS: a more sensitive technique to detect neurodegeneration associated with Alzheimer's disease
Ahmed et al. Utility of additional dedicated high-resolution 3T MRI in children with medically refractory focal epilepsy
Maton et al. Correlation of scalp EEG and 1H‐MRS metabolic abnormalities in temporal lobe epilepsy
Hammen et al. Magnetic resonance spectroscopy in epilepsy
Hammen et al. Identifying the affected hemisphere by 1H‐MR spectroscopy in patients with temporal lobe epilepsy and no pathological findings in high resolution MRI